Access count of this item: 248

Files in This Item:
File Description SizeFormat 
30_135.pdf587.14 kBAdobe PDFView/Open
Title: 神経因性膀胱に対するロバベロン錠(KN-7)の効果に関する研究
Other Titles: Therapeutic effect of Robaveron tablet (KN-7) on neurogenic bladder
Authors: 遠藤, 博志  KAKEN_name
園田, 孝夫  KAKEN_name
小柳, 知彦  KAKEN_name
丸, 彰夫  KAKEN_name
黒田, 一秀  KAKEN_name
高村, 孝夫  KAKEN_name
稲田, 文衛  KAKEN_name
六條, 正俊  KAKEN_name
大堀, 勉  KAKEN_name
久保, 隆  KAKEN_name
高田, 耕  KAKEN_name
鈴木, 安  KAKEN_name
中野, 修道  KAKEN_name
武田, 裕寿  KAKEN_name
安藤, 正夫  KAKEN_name
佐藤, 昭太郎  KAKEN_name
高木, 隆治  KAKEN_name
上原, 徹  KAKEN_name
安藤, 徹  KAKEN_name
黒田, 恭一  KAKEN_name
勝見, 哲郎  KAKEN_name
村山, 和夫  KAKEN_name
津川, 龍三  KAKEN_name
山川, 義憲  KAKEN_name
近藤, 厚生  KAKEN_name
小谷, 俊一  KAKEN_name
河田, 幸道  KAKEN_name
鄭, 漢彬  KAKEN_name
酒井, 俊助  KAKEN_name
説田, 修  KAKEN_name
中新井, 邦夫  KAKEN_name
山田, 薫  KAKEN_name
斉藤, 泰  KAKEN_name
岩崎, 昌太郎  KAKEN_name
由良, 守司  KAKEN_name
丸田, 耕一  KAKEN_name
Author's alias: Endo, Hiroshi
Sonoda, Takao
Koyanagi, Tomohiko
Maru, Akio
Kuroda, Kazuhide
Takamura, Takao
Inada, Fumie
Rokuzyo, Masatoshi
Ohori, Tsutomu
Kubo, Takashi
Takada, Kou
Suzuki, Yasushi
Nakano, Nobumichi
Takeda, Hirohisa
Ando, Masao
Sato, Shotaro
Takagi, Riuji
Uehara, Toru
Ando, Tetsu
Kuroda, Kyoichi
Katsumi, Tetsuo
Murayama, Kazuo
Tsugawa, Ryozo
Yamakawa, Yoshinori
Kondo, Atsuo
Otani, Toshikazu
Kawada, Yukimichi
Tei, Kanhin
Sakai, Shunsuke
Setsuda, Osamu
Nakarai, Kunio
Yamada, Kaoru
Saito, Yutaka
Iwasaki, Shotaro
Yura, Morishi
Maruta, Koichi
Keywords: Adult
Aged
Clinical Trials as Topic
Female
Humans
Male
Manometry
Middle Aged
Tablets
Tissue Extracts/administration & dosage/adverse effects/therapeutic use
Urinary Bladder/physiopathology
Urinary Bladder, Neurogenic/drug therapy/physiopathology
Urination
Issue Date: Jan-1984
Publisher: 泌尿器科紀要刊行会
Journal title: 泌尿器科紀要
Volume: 30
Issue: 1
Start page: 135
End page: 144
Abstract: Therapeutic effect of Robaveron Tablet (KN-7) was studied on 128 patients suffering from neurogenic bladder. Robaveron Tablet was administered 6 tablets daily for 3 weeks. The effect was evaluated by the residual urine, subjective symptoms, cystometric findings, urethral pressure profile and uroflowmetry. Remarkable decrease of residual urine was observed regardless of position of injury. The pressure amplitude defined as the difference between the maximum voiding pressure and the maximum resting pressure increased on any group of neurogenic bladder. The effectiveness, rated as moderately improved or better was 76.9% for brain disorders, 58.3% for upper motor neuron lesion and 75.7% for lower motor neuron lesion of spinal injuries, 58.3% for peripheral nervous injuries and 100% for others. No remarkable abnormality was observed in the results of side effects or clinical laboratory tests.
URI: http://hdl.handle.net/2433/118083
PubMed ID: 6375318
Appears in Collections:Vol.30 No.1

Show full item record

Export to RefWorks


Export Format: 


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.